OTCMKTS:BIEI Premier Biomedical - BIEI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Premier Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.0047 0.00 (0.00%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.0041▼$0.005050-Day Range N/A52-Week Range$0.0011▼$0.0069Volume12.43 million shsAverage Volume14.80 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest About Premier Biomedical (OTCMKTS:BIEI) StockPremier Biomedical, Inc. is a research-based company, which engages in the development and discovery of medical products. It focuses on the development and distribution of hemp oil based topical pain relief products. The company was founded by Mitchell S. Felder on May 10, 2010 and is headquartered in Southfield, MI.Read More Receive BIEI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Premier Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address BIEI Stock News HeadlinesFebruary 1, 2023 | finance.yahoo.comNova Graphene Ballistics (OTC PINK: BIEI) Retains Award Winning Communication Firm To Expand Public MessagingJanuary 19, 2023 | finance.yahoo.comPremier Biomedical Inc. (OTC PINK: BIEI), now known as Nova Graphene Ballistics, Inc., Releases its Graphene Ballistic Plate Production ApproachFebruary 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.December 20, 2022 | finance.yahoo.comPremier Biomedical Inc. (OTC PINK: BIEI), now known as Nova-Graphene Ballistics, Inc., Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production MethodologyDecember 14, 2022 | benzinga.comPremier Biomedical Stock (OTC:BIEI), Earnings Estimates, EPS, and RevenueAugust 12, 2022 | apnews.comBIOMEDevice Boston Brings Back “Master Class Start-Up Series” in Partnership with MassMEDICAugust 8, 2022 | ca.finance.yahoo.comPremier Biomedical, Inc. (BIEI)May 17, 2022 | apnews.comBioIVT to Provide Rare Biosamples for the FNIH Biomarkers Consortium Neurodegenerative Disease ProjectFebruary 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.October 26, 2021 | finance.yahoo.comPremier Biomedical Appoints Dr. Patricio Reyes to Board and Chief Technical OfficerNovember 15, 2020 | nasdaq.comBIEI After-Hours QuotesAugust 9, 2020 | barrons.comPremier Biomedical Inc.June 17, 2020 | www.bloomberg.comPremier Biomedical Inc., CEO William Hartman Visits Uptick Newswire’s “Stock Day” with Everett JollyJune 5, 2020 | www.finanznachrichten.deHalberd Corporation: Halberd Corp. Announces Correction/Clarification to Eliminate Name ConfusionJune 5, 2020 | finance.yahoo.comHalberd Corp. Announces Correction/Clarification to Eliminate Name ConfusionMay 12, 2020 | finance.yahoo.comPremier Biomedical, Technology Health, and Datatecnics Agree to Collaborate on Extracorporeal "Map and Zap(TM)" Coronavirus TreatmentMay 5, 2020 | www.finanznachrichten.dePremier Biomedical, Inc.: Premier Biomedical Rescinds Previously Planned Increase in Authorized SharesMay 5, 2020 | finance.yahoo.comPremier Biomedical Rescinds Previously Planned Increase in Authorized SharesApril 14, 2020 | finance.yahoo.comPremier Biomedical, Inc. Announces Second Covid-19 Treatment Provisional Patent Application Filed to Supplement Two Issued PatentsApril 8, 2020 | finance.yahoo.comPremier Biomedical, Halberd and Gold River Agree to Work Jointly to Develop Premier's Patented Extracorporeal Technology on COVID-19 Treatment And Proprietary Anti-Addiction Patch(TM)April 6, 2020 | finance.yahoo.comPremier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel Reverse Split & Fund Covid-19 R&DMarch 23, 2020 | finance.yahoo.comCovid-19 Treatment Provisional Patent Application Filed; Premier Biomedical, Inc. Granted Global Commercial RightsNovember 14, 2019 | www.finanznachrichten.dePremier Biomedical, Inc.: Premier Biomedical Announces Evolution of Business Focus and Name ChangeNovember 14, 2019 | finance.yahoo.comPremier Biomedical Announces Evolution of Business Focus and Name ChangeNovember 1, 2019 | markets.ft.comPremier Biomedical IncOctober 21, 2019 | finance.yahoo.comPremier Biomedical, Inc. CEO, William Hartman, Addresses Current Challenges with The Stock Day PodcastSeptember 19, 2019 | www.finanznachrichten.dePremier Biomedical, Inc. Joins The Stock Day Podcast to Announce The Release of Its Anti-Addiction PatchSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive BIEI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Premier Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:BIEI CUSIPN/A CIK1515740 Webwww.premierbiomedical.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesDavid CaplanChairmenJohn MaddoxChief Executive Officer & PresidentCarl EllerVice President-Marketing & PlanningBrain A. LebrechtSecurities CounselKey Competitors1933 IndustriesOTCMKTS:TGIFF4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFAcreageOTCMKTS:ACRHFView All Competitors BIEI Stock - Frequently Asked Questions How have BIEI shares performed in 2023? Premier Biomedical's stock was trading at $0.0044 on January 1st, 2023. Since then, BIEI shares have increased by 6.8% and is now trading at $0.0047. View the best growth stocks for 2023 here. Are investors shorting Premier Biomedical? Premier Biomedical saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 88,600 shares, an increase of 65.0% from the December 31st total of 53,700 shares. Based on an average daily volume of 19,650,200 shares, the days-to-cover ratio is presently 0.0 days. View Premier Biomedical's Short Interest. What other stocks do shareholders of Premier Biomedical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Premier Biomedical investors own include Co-Diagnostics (CODX), Allena Pharmaceuticals (ALNA), CytoDyn (CYDY), Inovio Pharmaceuticals (INO), Sierra Oncology (SRRA), Vaxart (VXRT), MEI Pharma (MEIP), Novavax (NVAX), Rigel Pharmaceuticals (RIGL) and Selecta Biosciences (SELB). What is Premier Biomedical's stock symbol? Premier Biomedical trades on the OTCMKTS under the ticker symbol "BIEI." How do I buy shares of Premier Biomedical? Shares of BIEI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Premier Biomedical's stock price today? One share of BIEI stock can currently be purchased for approximately $0.00. This page (OTCMKTS:BIEI) was last updated on 2/5/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.